Related Articles Even Market-Neutral Funds Couldn’t Escape the AI Slump in October Julie Segal It’s Biopharma or Bust for the IPO Market Stephen Taub Financing the World’s Essential Assets: The Growing Opportunity in Infrastructure Debt Sponsored by Principal Asset Management